December 12, 2025 – Attributable to Erik Haas, Worldwide Vice President of Litigation, Johnson & Johnson:
“The record reflects that the court made numerous legal errors that compelled the Company to move for a mistrial, which was denied. The Company has been successful in 16 of the 17 ovarian cancer cases it previously tried, demonstrating a strong track record that these cases have no scientific validity. We therefore will immediately appeal this verdict and expect to prevail as we typically do with aberrant adverse verdicts.
Today’s result is irreconcilable with the decades of independent scientific evaluations confirming that talc is safe, does not contain asbestos, and does not cause cancer. “These talc lawsuits clog courts and impose extraordinary costs on the judicial system with contrived ‘scientific’ debates that should be presented to and decided by the scientific agencies authorized by Congress to evaluate such questions. This why the Company continues to expose the plaintiff’s bar and their so-called experts through affirmative litigation.”
To learn more about our position and science supporting the safety of talc, visit www.FactsAboutTalc.com.
###